Filing Details
- Accession Number:
- 0001298709-24-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-11 20:24:19
- Reporting Period:
- 2024-03-11
- Accepted Time:
- 2024-03-11 20:24:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1711279 | Krystal Biotech Inc. | KRYS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1298709 | S Krish Krishnan | C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-03-11 | 2,146 | $167.99 | 1,635,116 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-11 | 2,254 | $168.88 | 1,632,862 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-11 | 5,109 | $170.32 | 1,627,753 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-11 | 8,002 | $170.93 | 1,619,751 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-11 | 2,816 | $172.06 | 1,616,935 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-11 | 3,359 | $173.09 | 1,613,576 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-11 | 1,314 | $174.00 | 1,612,262 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-11 | 2,658 | $168.15 | 1,573,224 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-03-11 | 1,646 | $168.96 | 1,571,578 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-03-11 | 8,040 | $170.42 | 1,563,538 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-03-11 | 5,469 | $171.09 | 1,558,069 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-03-11 | 2,800 | $172.21 | 1,555,269 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-03-11 | 3,587 | $173.30 | 1,551,682 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2024-03-11 | 800 | $174.13 | 1,550,882 | No | 4 | S | Indirect | By Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 90,000 | Indirect | By Krishnan Spousal Trust |
Common Stock | 50,000 | Indirect | By Krishnan Family Trust |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on September 11, 2023, and will terminate on September 11, 2024, and contemplates sales of 25,000 shares per quarter with a limit price of $100.00 per share.
- The transaction was executed in multiple trades ranging from $167.4900 to $168.4800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $168.4900 to $169.3300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $169.5400 to $170.5300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $170.5400 to $171.5100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $171.5700 to $172.5500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $172.5800 to $173.5300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $173.6800 to $174.5000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- These sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma M. Krishnan. The Rule 10b5-1 trading plan started on September 11, 2023, and will terminate on September 11, 2024, and contemplates sales of 25,000 shares per quarter with a limit price of $100.00 per share.
- These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma M. Krishnan.
- The transaction was executed in multiple trades ranging from $167.5700 to $168.5600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.
- The transaction was executed in multiple trades ranging from $168.5700 to $169.4900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $169.7600 to $170.7500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $170.7600 to $171.7500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $171.8300 to $172.8000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $172.9000 to $173.8800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $173.9000 to $174.5000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.